Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues

Department of Perinatal Medicine, Royal Women's Hospital, Carlton, Victoria, Australia.

The aims of this study were: to quantify immunoreactive tumour necrosis factor alpha (TNF-alpha) concentrations in maternal plasma and amniotic fluid obtained from women during pregnancy and labour, both at term and preterm; and to establish the effects of bacterial endotoxin and cytokines on the in vitro release of TNF-alpha from intrauterine tissues. Maternal plasma TNF-alpha concentrations did not change during pregnancy (457.2 +/- 102.9 ng/l, mean +/- SEM, N = 52) or at the time of labour (543.5 +/- 138.6 ng/l, N = 43). In contrast, amniotic fluid TNF-alpha concentrations increased significantly (p < 0.05) during pregnancy (early pregnancy, EP, 93.0 +/- 24.8 ng/l, N = 7; preterm not-in-labour, PNIL, 186.8 +/- 42.9 ng/l, N = 16; term not-in-labour. TNIL, 499.7 +/- 150.9 ng/l, N = 13) and in association with preterm labour (preterm in-labour, PIL, 958.7 +/- 575.6 ng/l, N = 5 vs PNIL, 186.8 +/- 42.9 ng/l, N = 16). Choriodecidual and placental explants (N = 3) maintained in in vitro culture released TNF-alpha. Furthermore, the release of TNF-alpha was increased significantly (p < 0.05) by bacterial endotoxin (lipopolysaccharide, 10 ng/l-10 mg/l) but was not affected by the following cytokines at the indicated doses: interleukin-1 alpha (0.28 nmol/l), interleukin-6 (12.5 nmol/l), granulocyte colony-stimulating factor (2.5 nmol/l), granulocyte-macrophage colony-stimulating factor (35 nmol/l), macrophage colony-stimulating factor (1.2 nmol/l), leukaemia inhibitory factor (0.45 nmol/l) and transforming growth factor-beta (0.4 nmol/l).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Lappas, M. Permezel, and G. E. Rice Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5627 - 5633. [Abstract] [Full Text] [PDF]

				M. Lappas, M. Permezel, H. M. Georgiou, and G. E. Rice Nuclear Factor Kappa B Regulation of Proinflammatory Cytokines in Human Gestational Tissues In Vitro Biol Reprod, August 1, 2002; 67(2): 668 - 673. [Abstract] [Full Text] [PDF]

				J. P. Kirwan, S. Hauguel-De Mouzon, J. Lepercq, J.-C. Challier, L. Huston-Presley, J. E. Friedman, S. C. Kalhan, and P. M. Catalano TNF-{alpha} Is a Predictor of Insulin Resistance in Human Pregnancy Diabetes, July 1, 2002; 51(7): 2207 - 2213. [Abstract] [Full Text] [PDF]

				N. Laham, S. P. Brennecke, and G. E. Rice Interleukin-8 Release from Human Gestational Tissue Explants: Effects of Gestation, Labor, and Chorioamnionitis Biol Reprod, September 1, 1999; 61(3): 823 - 827. [Abstract] [Full Text]

				D. L. Rivera, S. M. Olister, X. Liu, J. H. Thompson, X. Zhang, K. Pennline, R. Azuero, D. A. Clark, and M. J. S. Miller Interleukin-10 attenuates experimental fetal growth restriction and demise FASEB J, February 1, 1998; 12(2): 189 - 197. [Abstract] [Full Text]